The potential for a repeat of North America’s tech boom has some investors salivating, but a lack of exit opportunities remains an obstacle.
Category: Equity
Exito Buys Casino Businesses in Uruguay
Grupo Exito has signed an agreement to acquire Grupo Casino’s Disco, Devoto y Geant supermarket businesses in Uruguay for $746m. Casino holds a 62.5% in Disco and Geant, and a 96.5% stake in Devoto. The equity value implies a $926m enterprise value. Ebitda numbers at the target companies were not being disclosed. Exito plans a $1.4bn capital raise to finance the acquisition, with Casino subscribing for an amount equal to the value of the transaction. Barclays advised and JPMorgan advised Exito, while Casino was advised by Rothschild.
Kroton Raises BRL425m
Brazilian educator Kroton has priced a BRL425m ($266m) equity follow-on, coming at a 1.3% discount. The issuer priced 22.1m units, each consisting of 1 ordinary share and 6 preferred shares, at BRL19.25 each. Kroton’s share price had dropped 2.5% Wednesday to BRL19.50. The total includes a 15% greenshoe. In the deal, 0.8m shares are secondary shares sold by four minority holders. Kroton is raising funds to improve liquidity and expand. As Brazil’s middle class grows, the country’s private education sector is being rapidly consolidated by large listed operators such as Kroton, Estacio and Anhanguera. All three have now tapped the equity markets in the past 9 months to fuel their rapid expansion. Bradesco, BTG Pactual, Itau and Santander managed the Kroton transaction. Brazil’s Mahle-Metal Leve is scheduled to price today an approximately BRL300m follow-on of secondary shares sold by its German parent. Friday brings the IPO of E&P operation Perenco Brasil, which could raise BRL750m or more.
Medica Sur Prices Follow-on
Medica Sur priced a MXP743m ($63m) follow-on Wednesday at MXP24 per share. The transaction consisted of 25m secondary shares sold by local development bank Nafinsa, which owned a 21% stake in the Mexican hospital operator, worth about MXP602m at the follow-on price, and around 5m primary shares. Proceeds from the primary sale will mostly fund expansions and a refurbishment of a Tlalpan facility in Mexico City. Founded in 1982, Medica Sur operates hospitals and clinics and provides other health services including diagnostics, research and imaging in Mexico City, Monterrey, Cuernavaca and the state of Mexico. Ixe and BBVA Bancomer are managing the sale.
Minerva Convert Expected in July
Brazilian beef producer Minerva is expecting to price its BRL300m ($190m) domestic convertible bond on or around July 10. The preliminary prospectus had originally scheduled pricing on Wednesday. The 2015 bond is expected to pay a maximum of 100% of the DI rate, and be convertible at a price of BRL6.65-BRL8.85. Both the interest rate and the conversion price are to be determined during the bookbuilding process. Proceeds are to repay a BRL220m 2013 loan from Bradesco, which costs 119% of DI, and for working capital. Minerva is rated BBB minus on a national scale. S&P raised its outlook on the company to positive from stable earlier this week, citing Minerva’s improving capital structure and reduction of short-term refinancing risks. Goldman Sachs, Deutsche Bank and Banco do Brasil are managing the sale.
BR Properties Raises BRL690m
BR Properties has priced a BRL690m ($430m) equity follow-on, coming flat to Tuesday’s close. The commercial developer sold 40.3m primary shares at BRL17.15, matching the secondary level reached after shares fell 2.0% on the day. The total includes a 15% greenshoe. Proceeds will be used for acquisitions as BR Properties looks to consolidate its position in what is still a highly fragmented sector. Bradesco, Itau, Banco Safra and Santander managed the sale. BR Properties acquires, manages and develops offices, warehouses and retail centers in Sao Paulo, Rio de Janeiro and Parana states. It raised BRL1.07bn in its IPO in March 2010.
CB Auctions Banco de Chile Options
Chile’s central bank has priced a CLP24.35bn ($51.5m) notional-value sale of share options in Banco de Chile, according to the Santiago Bolsa. The 392.8m options to buy shares at CLP62 through July 4 represent the central bank’s preferential rights from Banco de Chile’s $180m equity follow-on in March. The options priced at CLP3.10 each. The central bank is a minority shareholder in Banco de Chile going back to a government intervention during a 1980s financial crisis, and had decided not to exercise its rights in the March sale. BanChile and LarrainVial managed the recent sale of options. Banco de Chile shares closed at CLP66.75 Tuesday. The CLP62 price matches the price of the 1.4bn share sale in March.
Technos IPO Comes at Low End
Brazilian watchmaker Technos has priced a BRL462m ($290m) IPO, scraping the bottom of its price range as a challenging week for Brazilian equity debuts continues. The 10.9m primary and 17.0m secondary shares priced at BRL16.50 each, at the low end of the BRL16.50-BRL20.50 range. The total includes a 15% greenshoe, which went entirely in the secondary portion. The relatively small size and the large number of equity offerings this week acted as headwinds for Technos, according to one New York-based EM equity investor who chose not to participate. “For larger institutional investors, they need to have a liquid stock.” With three IPOs and four follow-ons coming this week, it is a buyer’s market. Fellow Brazilian issuer and health benefits provider Qualicorp priced at BRL13 Monday, missing its BRL16-BRL19 range, while Chilean healthcare company Cruz Blanca disappointed by pricing at CLP500 last week, below its CLP525 floor. Brazil Pharma’s IPO also came in at the low end last week. Technos’ book generated strong interest among domestic accounts, and was evenly split between Brazilian and US/European investors, including institutional accounts from Brazil and new investors from the US and Europe, according to a banker on the deal. The transaction was over two times subscribed. Proceeds from the primary offering will go to finance the company’s growth plan, including potential acquisitions, payment of the acquisition of shares and to repay a loan with HSBC. The secondary shares were sold by Technos’ controlling group, which includes PE firm DLJ (40%) and Brazilian asset manager Dynamo (32%). Credit Suisse, Goldman Sachs and Itau managed the sale. Founded in 1956, the issuer owns the Technos and Mariner brands and also represents the Mormaii, Euro and Seiko lines in Brazil. On tap are follow-ons from Kroton tomorrow and Mahle-Metal Leve Thursday, as well as an IPO from Perenco Friday.
JBS Authorizes Share Purchase
JBS has authorized a share buyback program of up to 37.5m shares with the aim of increasing shareholder value, the company says. The schedule and exact number of shares to be acquired has not been disclosed. The Brazilian beef company’s stock climbed 0.39% Monday to close at BRL5.11.
Medica Sur Increases Follow-on
Medica Sur is increasing the size of a follow-on planned for this week to $68m, up from an original $60m deal. The transaction consists primarily of secondary shares to be sold by local development bank Nafinsa, which owns a 21% stake in the Mexican hospital operator, worth about MXP627 ($52.7m) at Monday’s closing price of MXP25 per share. Proceeds from the primary sale will mostly fund expansions and a refurbishment of a Tlalpan facility in Mexico City. Founded in 1982, Medica Sur operates hospitals and clinics and provides other health services including diagnostics, research and imaging in Mexico City, Monterrey, Cuernavaca and the state of Mexico. Ixe and BBVA Bancomer are managing the sale.
